Tiagabine

DRUG6 trials

Sponsors

National Institute on Drug Abuse (NIDA), Beth Israel Deaconess Medical Center, Rajesh Narendran, Brigham and Women's Hospital, Assistance Publique - Hôpitaux de Paris

Conditions

AlcoholismCocaine-Related DisordersEpilepsyOpiate DependenceSchizophreniaSleep Apnea, Obstructive

Phase 1

Characterization of [11C]Flumazenil to Image GABA Transmission in Healthy Adult Subjects and Subjects With Alcohol Dependence

CompletedNCT01904487

Rajesh NarendranAlcoholism

Start: 2011-04-19End: 2013-10-01Updated: 2017-08-29

Phase 2

Tiagabine for the Treatment of Cocaine Dependence - 1

CompletedNCT00086255

National Institute on Drug Abuse (NIDA)Cocaine-Related Disorders

Start: 2002-10-31End: 2004-06-30Target: 140Updated: 2017-01-12

Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1

CompletedNCT00129298

National Institute on Drug Abuse (NIDA)Cocaine-Related Disorders, Opiate Dependence

Start: 2004-12-31End: 2007-04-30Updated: 2017-01-12

Tiagabine to Enhance Slow Wave Sleep in Patients With Sleep Apnea

CompletedNCT02387710

Brigham and Women's HospitalSleep Apnea, Obstructive

Start: 2015-03-31End: 2016-07-31Updated: 2017-08-15

Phase 3

Treating Schizophrenia by Correcting Abnormal Brain Development

Active, not recruitingNCT00179465

Beth Israel Deaconess Medical CenterSchizophrenia

Start: 2003-11-30End: 2026-09-30Target: 36Updated: 2025-01-27

Unknown Phase

Population Pharmacokinetics of Antiepileptic in Pediatrics

CompletedNCT03196466

Assistance Publique - Hôpitaux de ParisEpilepsy

Start: 2017-06-19End: 2023-06-15Updated: 2025-11-20

Related Papers

An Evaluation of Substance Abuse Treatment and HIV Education on Safe Sex Practices in Cocaine Dependent Individuals

ISRN Addiction2014-03-043 citations